Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus

Department of Public and International Affairs, George Mason University, Manassas, VA 20110, USA.
BMC Immunology (Impact Factor: 2.25). 05/2010; 11:23. DOI: 10.1186/1471-2172-11-23
Source: PubMed

ABSTRACT At present, the relatively sudden appearance and explosive spread of HIV throughout Africa and around the world beginning in the 1950s has never been adequately explained. Theorizing that this phenomenon may be somehow related to the eradication of smallpox followed by the cessation of vaccinia immunization, we undertook a comparison of HIV-1 susceptibility in the peripheral blood mononuclear cells from subjects immunized with the vaccinia virus to those from vaccinia naive donors.
Vaccinia immunization in the preceding 3-6 months resulted in an up to 5-fold reduction in CCR5-tropic but not in CXCR4-tropic HIV-1 replication in the cells from vaccinated subjects. The addition of autologous serum to the cell cultures resulted in enhanced R5 HIV-1 replication in the cells from unvaccinated, but not vaccinated subjects. There were no significant differences in the concentrations of MIP-1alpha, MIP-1beta and RANTES between the cell cultures derived from vaccinated and unvaccinated subjects when measured in culture medium on days 2 and 5 following R5 HIV-1 challenge.
Since primary HIV-1 infections are caused almost exclusively by the CCR5-tropic HIV-1 strains, our results suggest that prior immunization with vaccinia virus might provide an individual with some degree of protection to subsequent HIV infection and/or progression. The duration of such protection remains to be determined. A differential elaboration of MIP-1alpha, MIP-1beta and RANTES between vaccinated and unvaccinated subjects, following infection, does not appear to be a mechanism in the noted protection.


Available from: Raymond S Weinstein, May 29, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Helping new members acculturate into online communities is crucial to developing successful and sustainable communities, but the process remains unexplored. To address this topic, this paper analyses antecedents and consequences of member's integration into online travel communities. Results show perceived similarity and reciprocity affect integration. Both integration and satisfaction with the community influence community participation. Finally, perceived reciprocity positively affects both satisfaction and intention to participate in the community. These findings suggest interesting implications for online travel community management.
    Journal of Business Research 06/2013; 66(6). DOI:10.1016/j.jbusres.2011.09.007 · 1.48 Impact Factor
  • Medicina Clínica 09/2011; 137(7):308-310. DOI:10.1016/j.medcli.2011.04.004 · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cross-reactive immunity occurs when infection with or vaccination against one virus protects against another related family member. A search for homologues of the HIV-1 envelope glycoprotein revealed that it is composed of thousands of intercalating and overlapping viral matches of pentapeptide or longer gapped consensi, belonging to over 70% of the currently sequenced virome, infecting all kingdoms from bacteria to man. It was also highly homologous to proteins from the Visna/Maedi and other ovine viruses, while other proteins (nef/tat/gag/pol) were homologous to proteins from the equine infectious anaemia virus and HTLV-2/HTLV-3 viruses. This phenomenon suggests that horizontal gene transfer from coinfecting RNA and DNA viruses to retroviruses is extensive, providing a route for the subsequent insertion of non-retroviral genes into human and other genomes via retroviral integration. This homology includes all viruses for which vaccines already exist. Cross-reactive immunity may be operative in AIDS, as Vaccinia vaccination decreases viral replication in HIV-1 infected patients' cells, for the CCR5 tropic form. Measles, Dengue virus, or GB virus C infections also decrease the HIV-1 viral load. A resumption of Vaccinia/smallpox vaccination might be expected to have a significant effect on the AIDS pandemic, and a careful study of the potential uses of other existing viral and bacterial vaccines merits close attention. This phenomenon may also be relevant to other recalcitrant viruses, bacteria, and parasites for which no vaccine exists and the armory of existing vaccines may have a role to play in diseases other than those for which they were designed.
    Immunopharmacology and Immunotoxicology 08/2011; 34(2):222-31. DOI:10.3109/08923973.2011.596542 · 1.11 Impact Factor